Navigation Links
New England Journal of Medicine Publishes New Data on Gardasil,,Merck's Cervical Cancer Vaccine

. Use with Hormonal Contraceptives In clinical studies, 13,293 subjects (vaccine = 6644; placebo = 6649) who had post-Month 7 follow-up used hormonal contraceptives for a total of 17,597 person-years (65.1% of the total follow-up time in the studies). Use of hormonal contraceptives or lack of use of hormonal contraceptives among study participants did not alter vaccine efficacy in the PPE population. Use with Systemic Immunosuppressive Medications Immunosuppressive therapies, including irradiation, antimetabolites, alkylating agents, cytotoxic drugs, and corticosteroids (used in greater than physiologic doses), may reduce the immune responses to vaccines (see PRECAUTIONS, General). Carcinogenesis, Mutagenesis, Impairment of Fertility GARDASIL has not been evaluated for the potential to cause carcinogenicity or genotoxicity. GARDASIL administered to female rats at a dose of 120 mcg total protein, which corresponds to approximately 300-fold excess relative to the projected human dose, had no effects on mating performance, fertility, or embryonic/fetal survival. Pregnancy Pregnancy Category B: Reproduction studies have been performed in female rats at doses up to 300 times the human dose (on a mg/kg basis) and have revealed no evidence of impaired female fertility or harm to the fetus due to GARDASIL. However, it is not known whether GARDASIL can cause fetal harm when administered to a pregnant woman or if it can affect reproductive capacity. GARDASIL should be given to a pregnant woman only if clearly needed. An evaluation of the effect of GARDASIL on embryo-fetal, pre- and postweaning development was conducted using rats. One group of rats was administered GARDASIL twice prior to gestation, during the period of organogenesis (gestation day 6) and on lactation day 7. A second group of pregnant rats was administered GARDASIL during the period of organogenesis (gestation day 6) and on lactation day 7 only. G
'"/>




Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32

Related medicine technology :

1. Research on New Treatment for Neglected Disease Published in The New England Journal of Medicine
2. Landmark Study Published in the New England Journal of Medicine Shows Important Benefits of Eprodisate (KIACTA) Treatment for Patients with Amyloid A (AA) Amyloidosis
3. Statement by Philip Home Chairman of the RECORD Study Steering Committee and Professor of Diabetes Medicine at Newcastle University in England
4. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
5. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
6. Peer Reviewed Journal Article Indicates Repros Proellex Exhibits Potential for New Approach to the Treatment and Prevention of Breast Cancer
7. New Study in Journal of Pediatrics Suggests Synagis (Palivizumab) May Reduce Subsequent Recurrent Wheezing in Preterm Infants
8. Genetics Journal Thimerosal/Autism Study the Best Science Drug Company Money Can Buy
9. Interim Analysis of Crinone Pregnancy Study to Be Published in American Society for Reproductive Medicine Journal
10. Nuvelo Announces Publication of Phase 2 rNAPc2 Study Results in Journal of American College of Cardiology
11. Trophos Publishes ALS Article in Journal of Pharmacology and Experimental Therapeutics
Post Your Comments:
(Date:7/7/2015)... -- Research and Markets ( ... "The New Trends of Global Preclinical Development ... The report, The New Trends of Global ... the current development states and the future growth ... The report is designed to reveal the latest ...
(Date:7/7/2015)... MILAN , July 7, 2015 /PRNewswire/ ... que la société P&R annonce l,acquisition de ... active au niveau mondial, spécialisée dans la ... à base d,acide hyaluronique.      ... est l,un des principaux groupes chimiques et ...
(Date:7/7/2015)... WASHINGTON , July 7, 2015 Noting ... and opaque" pricing policies currently practiced by the rapidly ... Pharmacy Coalition (SCPC) today praised Ohio ... into law a new state effort to help pull ... practices. "We applaud Governor Kasich for ...
Breaking Medicine Technology:New Trends in the 2015 Global Preclinical Development Outsourcing Market 2New Trends in the 2015 Global Preclinical Development Outsourcing Market 3New Trends in the 2015 Global Preclinical Development Outsourcing Market 4New Trends in the 2015 Global Preclinical Development Outsourcing Market 5National LTC Pharmacy Leader Praises Kasich Effort to Bring Transparency to PBM Drug Pricing 2National LTC Pharmacy Leader Praises Kasich Effort to Bring Transparency to PBM Drug Pricing 3
... 2011 A new report in the March issue of ... beat brand names when it comes to safety, efficacy, and ... drug programs offering these drugs at prices as low as ... Walgreens, and Walmart have been steadily expanding their discount programs, ...
... JumpStart Ventures , the non-profit that invests in ... Ohio, and Cleveland Clinic , announced a ... Inc. The Cleveland-based company is developing a topical ... formation in wounds. (Logo: http://photos.prnewswire.com/prnh/20060209/CLJUMPSTARTLOGO) ...
Cached Medicine Technology:Consumer Reports Health: Best Drugs for What Ails You, Plus Where to Buy Them for $4 a Month 2Consumer Reports Health: Best Drugs for What Ails You, Plus Where to Buy Them for $4 a Month 3Consumer Reports Health: Best Drugs for What Ails You, Plus Where to Buy Them for $4 a Month 4JumpStart Ventures and Cleveland Clinic Invest in SironRX Therapeutics 2JumpStart Ventures and Cleveland Clinic Invest in SironRX Therapeutics 3JumpStart Ventures and Cleveland Clinic Invest in SironRX Therapeutics 4
(Date:7/7/2015)... ... 07, 2015 , ... Leading healthcare consulting firm Hammes Company ... Vice President, heading the firm’s Healthcare Advisory Services division. , Mr. Warden will ... providers’ needs in ways that strengthen their position in the marketplace. The Healthcare ...
(Date:7/7/2015)... ... ... a reputable source of authentic tickets for the 2015 CONCACAF Gold Cup Group A matches ... Stadium. , The 2015 CONCACAF Gold Cup is now upon us as Group A ... soil, will kick off in Frisco, CA from the Toyota Stadium and will feature two ...
(Date:7/7/2015)... ... July 07, 2015 , ... Greatist today announced the ... helps active people find the most fun activities to do with friends. , The ... It also increases Greatist’s opportunity for events, e-commerce, and brand partnerships. , “I’ve been ...
(Date:7/7/2015)... N.J. (PRWEB) , ... July ... ... CTLT), the leading global provider of advanced delivery technologies and development solutions ... signed an exclusive licensing agreement with Excelimmune, Inc. to access its antibody ...
(Date:7/7/2015)... ... July 07, 2015 , ... Healthpointe is ... team. Dr. Alupay, an anesthesiologist and pain management specialist, will be evaluating and treating ... as neurological conditions. , After receiving his Bachelor of Science in Biology from the ...
Breaking Medicine News(10 mins):Health News:Hammes Company Hires Jay Warden to Lead Healthcare Advisory Services 2Health News:Hammes Company Hires Jay Warden to Lead Healthcare Advisory Services 3Health News:Panama vs Haiti & USA vs Honduras CONCACAF Group A Tickets at Toyota Stadium: Ticket Down Slashes Ticket Prices for Haiti vs Panama & USA vs Honduras in Frisco/Dallas 2Health News:Panama vs Haiti & USA vs Honduras CONCACAF Group A Tickets at Toyota Stadium: Ticket Down Slashes Ticket Prices for Haiti vs Panama & USA vs Honduras in Frisco/Dallas 3Health News:Greatist Acquires Active Lifestyle Brand Blood, Sweat & Cheers 2Health News:Catalent Biologics Adds New Technology Platform to Enable Antibody Combination Therapies 2Health News:Dr. Pedro S. Alupay, M.D., Now Providing Pain Management Services at Healthpointe in Irwindale 2Health News:Dr. Pedro S. Alupay, M.D., Now Providing Pain Management Services at Healthpointe in Irwindale 3
... prepare for a day without cigarettes and tobacco products ... Smokeout (R) (November 21), new research gives them more ... to the American Academy of Otolaryngology-Head and Neck Surgery ... organization,s annual meeting in September 2008 are studies that ...
... Nelson, PhD, served as vice-chair of the advisory committee ... by the U.S. Department of Health and Human Services ... for Physical Activity and Nutrition and Associate Professor of ... Policy at Tufts. , "After reviewing a ...
... A further new multidisciplinary journal in the neurosciences, ... March 2009. With this addition to its publishing ... of research, current practices and future trends in the ... the gap between the life sciences, social sciences, engineering, ...
... Institute have found that reducing the levels of vascular endothelial ... of new blood vessel growth, in adult mice causes the ... retina that are essential to visual function. This finding, published ... implications for the chronic use of promising new anti-VEGF drugs ...
... WOBURN, Mass., Nov. 3 Culbert Healthcare,Solutions, ... services firm, announced today that Norm Botsford ... the Strategic Services practice., Mr. Botsford ... Officer,at University Physicians Healthcare (UPH), the health ...
... Scientists at Schepens Eye Research,Institute have found that reducing ... best known as a stimulator of new blood,vessel growth, ... Muller,glia -- cells of the retina that are essential ... 2008 PLoS ONE, holds implications for,the chronic use of ...
Cached Medicine News:Health News:Smokers see decline in ability to smell, rise in laryngitis, and upper airway issues 2Health News:Tufts' Nelson a leader on Physical Activity Guidelines advisory committee 2Health News:Springer launches Cognitive Computation 2Health News:Anti-VEGF drugs for retinal diseases could have serious side effects, scientists caution 2Health News:Anti-VEGF drugs for retinal diseases could have serious side effects, scientists caution 3Health News:Norm Botsford Joins Culbert Healthcare Solutions' Strategic Services Team 2Health News:Anti-VEGF Drugs for Retinal Diseases Could Have Serious Side Effects, Scientists Caution 2Health News:Anti-VEGF Drugs for Retinal Diseases Could Have Serious Side Effects, Scientists Caution 3
The latest addition to Aerotels Transtelephonic ECG product line, HeartOne™ is a unique miniaturized single-lead, 4-event recorder/transmitter designed for transmission on cellular (GSM) and an...
... Tamtron PowerPath is IMPACs comprehensive ... anatomic pathology laboratories to integrate and ... needs through a single, intuitive software ... more than 350 institutions have proven ...
... is IMPACs comprehensive information system designed ... to integrate and streamline their diagnostic, ... single, intuitive software solution. Thousands of ... institutions have proven PowerPaths unique "case-centric ...
The most compact revolutionary innovation in hematology. 26 paramaters with 5 part DIFF....
Medicine Products: